VistaGen Therapeutics, Inc.
VTGN
$1.97
-$0.08-3.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.64M | -14.09M | -12.96M | -10.73M | -9.52M |
| Total Depreciation and Amortization | 166.00K | 161.00K | 157.00K | 151.00K | 147.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 835.00K | 978.00K | 972.00K | 1.14M | 528.00K |
| Change in Net Operating Assets | 2.57M | 2.67M | 946.00K | -1.43M | 1.86M |
| Cash from Operations | -10.06M | -10.28M | -10.89M | -10.87M | -6.99M |
| Capital Expenditure | -88.00K | 0.00 | -61.00K | -42.00K | -29.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 615.00K | -422.00K | -7.73M | -5.43M | -- |
| Cash from Investing | 527.00K | -422.00K | -7.79M | -5.47M | -29.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 1.95M | 1.17M | 0.00 | 88.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -380.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.95M | 1.17M | 0.00 | 88.00K | -380.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.58M | -9.53M | -18.67M | -16.25M | -7.39M |